<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-114508</identifier>
<setSpec>1889-7347</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Palliative care of advanced thymic neuroendocrine carcinoma</dc:title>
<dc:description xml:lang="en">Neuroendocrine tumors of the thymus are uncommon with limited therapeutic options. We report a 44-year-old man with superior vena cava syndrome associated with thymic neuroendocrine carcinoma with bone metastases, the subject received cytotoxic chemotherapy, radiotherapy and subsequently everolimus associated with Lanreotide achieving a progressionfree tumor (AU)</dc:description>
<dc:creator>Villagran Rojas, L. K</dc:creator>
<dc:creator>Gonzalez Devia, D</dc:creator>
<dc:creator>Conrado Rodero, Z</dc:creator>
<dc:creator>Lopez Panqueva, R</dc:creator>
<dc:creator>Vargas Baez, C</dc:creator>
<dc:creator>Santacruz Escudero, J. G</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Los tumores neuroendocrinos de timo son infrecuentes con opciones terapéuticas limitadas. Reportamos un hombre de 44 años con síndrome de vena cava superior asociado a Carcinoma neuroendocrino de timo con metástasis óseas; recibió quimioterapia citotóxica, radioterapia y posteriormente everolimus asociado a Lanreotide lográndose sobrevida libre de progresión (AU)</dc:description>
<dc:source>Rev. esp. patol. torac;25(2): 143-147, abr.-jun. 2013. ilus</dc:source>
<dc:identifier>ibc-114508</dc:identifier>
<dc:title xml:lang="es">Manejo paliativo del carcinoma neuroendocrino de timo</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d9555</dc:subject>
<dc:subject>^d31255^s22053</dc:subject>
<dc:subject>^d2319^s22053</dc:subject>
<dc:subject>^d14341^s22053</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d19562^s22012</dc:subject>
<dc:subject>^d7344^s22073</dc:subject>
<dc:subject>^d10353^s22045</dc:subject>
<dc:subject>^d1884^s22064</dc:subject>
<dc:type>article</dc:type>
<dc:date>201306</dc:date>
</metadata>
</record>
</ibecs-document>
